Business
The Future of CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals Inc. (CSE: ORI), Aurora Cannabis Inc., CannTrust Holdings Inc., Kalytera Therapeutics
The Future of CBD for Pain Treatment and Sports Medicine: Orion Nutraceuticals Inc. (CSE: ORI), Aurora Cannabis Inc., CannTrust Holdings Inc., Kalytera Therapeutics.
About this update from Claritas Pharmaceuticals Inc.
[{"type":"text","content":"\nPOINT ROBERTS, Wash. and KELOWNA, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Investorideas.com, a leading investor news resource for cannabis stocks releases a snapshot looking at CBD and its future role as a pain treatment in healthcare, and how it is being advocated and embraced by professional athletes.\n The World Anti-Doping Agency (WADA) officially removed cannabidiol (CBD) from its Prohibited Substances List effective January 1, 2018 and that has opened up a lot of opportunity for athletes looking for more natural pain treatment solutions and companies in the space. In June of this year, The BIG3 basketball league announced they will allow players to use cannabidiol (CBD) as a pain treatment and for recovery. \"The BIG3 is uniquely positioned in professional sports as a player-powered league that looks at our players as partners not property,\" BIG3 co-founder and co-CEO Jeff Kwatinetz said in a statement. \"As a testament to our relationship with our players, we listened to their feedback on CBD, as well as feedback from professionals in the regulatory and CBD industry, and decided to take this major step to support their health.\" NFL Players are some of the biggest advocates of the use of CBD for pain and sports injuries and as a Washington Post article explains, “No professional sport has so many outspoken proponents of marijuana’s medicinal qualities, but then again, no sport is as closely associated with pain and injury.” Looking at capitalizing on the CBD market opportunity, cannabis life science company Orion Nutraceuticals Inc. (CSE: ORI), just announce today it is entering the sports medicine CBD market with the addition of Shannon Ford-Smith, sports healthcare and CBD product expert to its advisory board. From the news: Shannon Ford-Smith has a uniquely diverse background that includes education, construction, consumer goods as well as experience building and leading companies in the sports healthcare sector. She has over a decade of experience building, leading and establishing business direction. Continued: Throughout her career she has developed deep market insight into the healthcare field. Her recent executive role at Floydʼs of Leadville as Director of Business Development includes the development of Aeliza (a medical grade CBD product line) and oversight of the Company&#...